A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity-Reference-Cited by-同舟云学术

A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity

Published:2022-07-01 Issue:7 Volume:70 Page:477-482
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

Nakagawa Riko¹,Tateishi Hiroshi¹,Radwan Mohamed O.¹,Chinen Takuma¹,Ciftci Halilibrahim²,Iwamaru Kana¹,Baba Nanami¹,Tominaga Yuna¹,Koga Ryoko¹,Toma Tsugumasa¹,Inoue Jun-ichiro³,Umezawa Kazuo⁴,Fujita Mikako¹,Otsuka Masami¹

Affiliation:

1. Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University

2. Department of Drug Discovery, Science Farm Ltd.

3. Research Platform Office, The Institute of Medical Science, The University of Tokyo

4. Department of Molecular Target Medicine, Aichi Medical University School of Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

https://www.jstage.jst.go.jp/article/cpb/70/7/70_c21-01087/_pdf

Reference29 articles.

1. 1) Babula P., Adam V., Havel L., Kizek R., Curr. Pharm. Anal., 5, 47–68 (2009).

2. 2) Tandon V. K., Kumar S., Expert Opin. Ther. Pat., 23, 1087–1108 (2013).

3. 3) Wellington K. W., RSC Adv., 5, 20309–20338 (2015).

4. 4) Aminin D., Polonik S., Chem. Pharm. Bull., 68, 46–57 (2020).

5. 5) Kumagai Y., Abiko Y., Cong N. L., J. Toxicol. Sci., 41 (Special), Sp37–sp47 (2016).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salivary metabolomic identification of biomarker candidates for oral melanoma and oral squamous cell carcinoma in dogs;Journal of Veterinary Internal Medicine;2024-05-04

2. Synthesis and Evaluation of DHMEQ Derivatives with Tertiary Hydroxyl Group Instead of Secondary Hydroxyl Group;Chemical and Pharmaceutical Bulletin;2023-04-01

3. Research status of indole-modified natural products;RSC Medicinal Chemistry;2023

4. New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia;Pharmaceuticals;2022-12-17